Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Kidney Cancer DNA Registry

Memorial Sloan Kettering Cancer Center · NCT02087852

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
750
US sites recruiting
7
Study start
March 2014
Record last updated
April 9, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This registry will help us develop better methods of:

  • Preventing these cancers
  • Diagnosing these cancers
  • Treating these cancers

Being studied: salvia for germline DNA; the Kidney Cancer Questionnaire; Family History Questionnaire (when applicable); Blood draw; Epidemiologic Questionnaire

Conditions: Renal Cancer

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

Kidney Cancer Case Cohort

  • Must be ≥ 18 years of age AND
  • Must be an English-speaker AND
  • Must have a diagnosis or suspicion of kidney cancer

Family Member Cohort

  • Must be ≥ 18 years of age AND
  • Must be an English-speaker AND
  • Must be a blood relative of the proband. Family members of probands including mother, father, sisters, brothers, half-sisters, half-brothers, daughters, sons, grandmothers, grandfathers, as well as aunts and uncles are eligible. These individuals need not have kidney cancer, as they will be used for segregation analysis of suspected variants found in the proband; requesting DNA from relatives is required.

Control Cohort

  • Must be ≥ 18 years of age AND
  • Must be an English-speaker AND
  • Must not have a personal history of cancer, with the exception of nonmelanoma skin cancer, AND
  • Must not be a blood relative of any cases or controls enrolled in this study

Exclusion Criteria

  • Patients who, in the opinion of the primary MSKCC clinician or the investigator, have a condition that precludes their ability to provide an informed consent

Recruiting US locations

  • Memorial Sloan Kettering at Basking Ridge (Consent and Follow-up)

    Basking Ridge, NJ 07920

    Site contact: Jonathan Coleman, MD · 646-422-4432

  • Memorial Sloan Kettering Monmouth (Consent and Follow up)

    Middletown, NJ 07748

    Site contact: Jonathan Coleman, MD · 646-422-4432

  • Memorial Sloan Kettering Bergen (Consent and Follow up )

    Montvale, NJ 07645

    Site contact: Jonathan Coleman, MD · 646-422-4432

  • Memorial Sloan Kettering Commack (Consent and Follow-up)

    Commack, NY 11725

    Site contact: Jonathan Coleman, MD · 646-422-4432

  • Memorial Sloan Kettering Westchester (Consent and Follow up)

    Harrison, NY 10604

    Site contact: Jonathan Coleman, MD · 646-422-4432

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, NY 10065

    Site contact: Jonathan Coleman, MD · 646-422-4432

  • Memorial Sloan Kettering Nassau (Consent and Follow-Up)

    Uniondale, NY 11553

    Site contact: Jonathan Coleman, MD · 646-422-4432

Study contacts (from the official record)

  • Jonathan Coleman, MD · 646-422-4432
  • Kenneth Offit, MD · 646-888-4050
Kidney Cancer DNA Registry (NCT02087852) | Bored Studies